Navigation Links
Idenix in Medical News

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

... Biochemical Labs, Inc., HemispheRx Biopharma, Inc., Human Genome Sciences, idenix Pharmaceuticals, Inc., Innogenetics NV, InterMune, Inc., Intarcia Therapeut...pheRx Biopharma, Inc. (USA) II-72 Human Genome Sciences (USA) II-72 idenix Pharmaceuticals, Inc. (USA) II-73 Innogenetics NV (Belgium) II-73 I...

Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences

...AMBRIDGE, Mass., March 3 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced ... can be accessed under "Calendar of Events" in the idenix Investor Center at www.idenix.com . Please log i...on. The archived replays will be available on the idenix website for two weeks following the conferences. ...

Idenix Pharmaceuticals to Present at the PiperJaffray 20th Annual Health Care Conference

...AMBRIDGE, Mass., Nov. 25 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced today that idenix management will participate in the PiperJaffray An... can be accessed under "Calendar of Events" in the idenix Investor Center at www.idenix.com . Please log i...

Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences

... can be accessed under "Calendar of Events" in the idenix Investor Center at http://www.idenix.com . Please... weeks following the conferences. About Idenix idenix Pharmaceuticals, Inc., headquartered in Cambridge,...Idenix, please refer to http://www.idenix.com . idenix Pharmaceuticals' Contacts: Media: Teri Dahlman (...

Idenix to Host Conference Call Discussing First Quarter 2008 Financial Results

...ast of the call, go to "Calendar of Events" in the idenix Investor Center at http://www.idenix.com . A repl...r the call on the Idenix website. About Idenix idenix Pharmaceuticals, Inc., headquartered in Cambridge,...Idenix, please refer to http://www.idenix.com . idenix Pharmaceuticals' Contact: Media: Teri Dahlman (6...

Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference

...ticals, Inc. (Nasdaq: IDIX ) announced today that idenix management will present an overview of its Hepatit... can be accessed under "Calendar of Events" in the idenix Investor Center at http://www.idenix.com . Please...ion. The archived replays will be available on the idenix website for two weeks following the conference. ...

Idenix Pharmaceuticals to Present at the Eleventh Annual Lehman Brothers Global Healthcare Conference

...ticals, Inc. (Nasdaq: IDIX ) announced today that idenix management will present a corporate overview at th... can be accessed under "Calendar of Events" in the idenix Investor Center at http://www.idenix.com . Please...ion. The archived replays will be available on the idenix website for two weeks following the conference. ...

Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results

...e product sales. As a result of these changes, idenix reduced its workforce by approximately 100 positio... in late-stage preclinical testing. "In 2007, idenix experienced a great deal of change, which enabled ... For the fourth quarter ended December 31, 2007, idenix reported total revenues of $12.6 million, compared...

Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference

...ticals, Inc. (Nasdaq: IDIX ) announced today that idenix management will present a corporate overview at th... can be accessed under "Calendar of Events" in the idenix Investor Center at http://www.idenix.com . Please...ion. The archived replays will be available on the idenix website for two weeks following the conference. Th...

Idenix Pharmaceuticals to Present at the JP Morgan 26th Annual Healthcare Conference

...ticals, Inc. (Nasdaq: IDIX ) announced today that idenix management will present a corporate overview, incl... can be accessed under "Calendar of Events" in the idenix Investor Center at http://www.idenix.com . Please...tion. The archived replay will be available on the idenix website for two weeks following the conference. ...
Idenix in Medical Technology

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

...AMBRIDGE, Mass., July 20 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biophar...eted a three-day proof-of-concept study of IDX184. idenix is developing IDX184, a novel liver-targeted prodr... drug. Conference Call Information idenix will hold a conference call and webcast today at 4...

Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV

...Mass. and LONDON, Feb. 6 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) and GlaxoS...n Phase II clinical development being developed by idenix for the treatment of HIV/AIDS. New NNRTIs are nee...esponsibility and associated costs for IDX899, and idenix will receive an upfront payment of $34 million and...

Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

...AMBRIDGE, Mass., Jan. 12 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biophar...ceiving placebo. 2008 Financial Guidance idenix today reported that it ended 2008 with approximate... results have not yet been audited. About idenix ...

Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients

... relevant drug-drug interactions. About Idenix idenix Pharmaceuticals, Inc., headquartered in Cambridge,...t any date subsequent to the date of this release. idenix anticipates that subsequent events and development...expectations and beliefs to change. However, while idenix may elect to update these forward-looking statemen...

Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic

...D-enabling pharmacokinetic and toxicology studies. idenix has also advanced two protease inhibitor drug cand...ts. IDX375 Non-Nucleoside Polymerase Inhibitor idenix has selected IDX375 as its lead clinical candidate...DX136 and IDX316 Macrocyclic Protease Inhibitors idenix has scaled up manufacturing of two clinical candid...

Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients

...stance Workshop in Sitges, Spain. About Idenix idenix Pharmaceuticals, Inc., headquartered in Cambridge,...t any date subsequent to the date of this release. idenix anticipates that subsequent events and development...expectations and beliefs to change. However, while idenix may elect to update these forward-looking statemen...

Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results

...ion. 2008 Year-to-Date Business Highlights -- idenix reported positive data from an ongoing phase I/II ...udy of the Liver (EASL) last week. (Please see idenix press release dated April 23, 2008 for more in...ed in the second half of 2008. -- idenix also reported positive preclinical data from its H...

Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)

...andring, Ph.D., executive vice president, biology, idenix Pharmaceuticals, in an oral presentation session a...rogram Based on two novel macrocyclic scaffolds, idenix has discovered compounds that demonstrated potency...f selected human cellular proteases. In vitro, the idenix protease inhibitors exhibited antiviral activity a...

IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a Phase I/II Clinical Trial in Treatment-Naive HIV-Infected Patients

...e not markedly altered by IDX899. About Idenix idenix Pharmaceuticals, Inc., headquartered in Cambridge,...t any date subsequent to the date of this release. idenix anticipates that subsequent events and development...expectations and beliefs to change. However, while idenix may elect to update these forward-looking statemen...

Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference

... SAN FRANCISCO, Jan. 7 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharm.... Novel Macrocyclic Protease Inhibitor Program idenix is evaluating multiple scaffolds in its protease i...V treatment paradigm." 2007 Financial Guidance idenix today reaffirmed prior 2007 financial guidance of ...
Idenix in Biological Technology

Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock

...CAMBRIDGE, Mass., Aug. 5 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biophar...fective by the Securities and Exchange Commission. idenix also will file with the Securities and Exchange Co...ree, at 1-800-808-7525, Ext. 4814. About idenix ...

Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results

...AMBRIDGE, Mass., July 20 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biophar... million. Business Highlights idenix announced today that it had successfully completed...dvance its two preclinical HCV antiviral programs. idenix is finalizing IND- or CTA-enabling preclinical stu...

Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results

...AMBRIDGE, Mass., July 14 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc., (Nasdaq: IDIX ) announced...onjunction with the issuance of the press release, idenix management will host a conference call at 4:30 p.m...mpanying slides, go to "Calendar of Events" in the idenix Investor Center at www.idenix.com. A replay of the...

Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference

...CAMBRIDGE, Mass., May 11 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced today that idenix management will present a corporate overview at th... can be accessed under "Calendar of Events" in the idenix Investor Center at www.idenix.com . Please log...

Idenix Pharmaceuticals Reports First Quarter Financial Results

...MBRIDGE, Mass., April 30 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biophar...$17 million representing the purchase of shares of idenix common stock by GSK. idenix may also be eligible to receive up to $416 million...

Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver

...MBRIDGE, Mass., April 23 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biophar...hen combined with standard-of-care agents or other idenix compounds in development (IDX184 and IDX375). Favo...doses of 10 or 100 mg/kg for 7 days. About idenix ...

Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference

...AMBRIDGE, Mass., April 3 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced ... can be accessed under "Calendar of Events" in the idenix Investor Center at www.idenix.com . Please log...on. The archived replays will be available on the idenix website for two weeks following the conferences. ...

Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)

...MBRIDGE, Mass., March 18 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biophar...on; Thursday, April 23, 2009 About idenix idenix Pharmaceuticals, Inc., headquartered in Cambridge,...

Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results

...AMBRIDGE, Mass., Feb. 17 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biophar...ion. Business Highlights idenix successfully completed a phase I/II proof-of-conce...$17 million representing the purchase of shares of idenix common stock by GSK....

Idenix to Host Conference Call Discussing Fourth Quarter 2008 Financial Results

...AMBRIDGE, Mass., Feb. 11 /PRNewswire-FirstCall/ -- idenix Pharmaceuticals, Inc., (Nasdaq: IDIX ) announced...onjunction with the issuance of the press release, idenix management will host a conference call at 4:30 p.m...ast of the call, go to "Calendar of Events" in the idenix Investor Center at www.idenix.com . A replay of ...
Other Tags
(Date:9/3/2015)... CA (PRWEB) , ... September 03, 2015 , ... ProScrub ... easily create back & forth, flicker, repeat, and custom speed effects without the use ... and the speed of effect. ProScrub tools are perfect complements to energetic video ...
(Date:9/3/2015)... ... ... Mum n Me is pleased to announce the launch of its ... maximum protection from sun exposure, wind, bugs, and germs. The Mum n Me Baby ... keeping the cover securely in place. The new car seat cover is made with ...
(Date:9/3/2015)... ... ... new cases of prostate cancer are reported each year, along with 27,540 deaths attributed to ... lifetime. While only one man in 10,000 will typically get prostate cancer under age 40, ... American Cancer Society. , Prostate cancer is the second leading cause ...
(Date:9/3/2015)... ... September 03, 2015 , ... The partnership will ... and technical support services to promote LodonalTM in Nigeria. The distribution will become ... efficacy and safety of the product. , Managing Director, Fidson Healthcare Plc, Dr ...
(Date:9/2/2015)... ... September 03, 2015 , ... ... University Bloomberg School of Public Health and an internationally recognized scholar on obesity ... for 2015-16. Dr. Bleich, a Baltimore native and 1996 graduate of Garrison Forest ...
Breaking Medicine News(10 mins):Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:Mum n Me Announces New Baby Car Seat Cover 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2
(Date:8/20/2015)... SANTA CLARA, Calif. , Aug. 20, 2015 ... based company focused on improving the user experience ... voice and vision technologies, today announced that its ... and voice biometric authentication software to be ... Alliance tested TrulySecure for compliance with the FIDO ...
(Date:8/18/2015)... N.J. , Aug. 18, 2015 /PRNewswire/ ... a key contributor to the Submission Content ... by IRISS, a non-profit forum. Dedicated to the ... provides a neutral platform for industry, vendors, ... share information and work towards a standard ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
Breaking Biology News(10 mins):TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3MedNet Solutions Experiences Explosive Corporate Growth 2
Other Contents